Variant report
Variant | nsv558719 |
---|---|
Chromosome Location | chr12:43020633-43031988 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:64)
- CpG islands (count:183)
- Chromatin interactive region (count:4)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:43025444-43025655 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr12:43025322-43025688 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr12:43025330-43025600 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr12:43025345-43025677 | IMR90 | lung: | n/a | n/a |
5 | CEBPB | chr12:43025359-43025674 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | CTCF | chr12:43030904-43030941 | Fibrobl | skin: | n/a | n/a |
7 | CTCF | chr12:43031010-43031045 | MCF-7 | breast: | n/a | n/a |
8 | CTCF | chr12:43031000-43031007 | MCF-7 | breast: | n/a | n/a |
9 | CTCF | chr12:43030939-43030957 | GM12891 | blood: | n/a | n/a |
10 | EP300 | chr12:43024204-43024416 | K562 | blood: | n/a | n/a |
11 | EP300 | chr12:43025398-43025636 | Hela-S3 | cervix: | n/a | n/a |
12 | GATA2 | chr12:43031819-43032358 | HUVEC | blood vessel: | n/a | n/a |
13 | HEY1 | chr12:43030708-43031038 | HepG2 | liver: | n/a | n/a |
14 | HEY1 | chr12:43030843-43031068 | K562 | blood: | n/a | n/a |
15 | HEY1 | chr12:43030866-43031003 | HepG2 | liver: | n/a | n/a |
16 | KAP1 | chr12:43023782-43024522 | U2OS | brain: | n/a | n/a |
17 | KAP1 | chr12:43023607-43024511 | HEK293 | kidney: | n/a | n/a |
18 | MAX | chr12:43027528-43027577 | NB4 | blood: | n/a | chr12:43027560-43027570 |
19 | MAZ | chr12:43027324-43027341 | HepG2 | liver: | n/a | n/a |
20 | MYC | chr12:43030871-43030980 | MCF-7 | breast: | n/a | n/a |
21 | MYC | chr12:43030791-43030974 | MCF-7 | breast: | n/a | n/a |
22 | MYC | chr12:43030905-43030970 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr12:43030846-43031007 | Hela-S3 | cervix: | n/a | n/a |
24 | POLR2A | chr12:43030847-43031011 | A549 | lung: | n/a | n/a |
25 | POLR2A | chr12:43030887-43030981 | A549 | lung: | n/a | n/a |
26 | POLR2A | chr12:43030830-43031015 | GM12878 | blood: | n/a | n/a |
27 | POLR2A | chr12:43030890-43030975 | A549 | lung: | n/a | n/a |
28 | POLR2A | chr12:43023525-43023576 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr12:43026076-43026105 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr12:43030694-43030964 | H1-hESC | embryonic stem cell: | n/a | n/a |
31 | POLR2A | chr12:43030849-43030991 | HepG2 | liver: | n/a | n/a |
32 | POLR2A | chr12:43030881-43031017 | A549 | lung: | n/a | n/a |
33 | POLR2A | chr12:43030847-43031069 | H1-hESC | embryonic stem cell: | n/a | n/a |
34 | POLR2A | chr12:43030811-43031049 | GM12878 | blood: | n/a | n/a |
35 | POLR2A | chr12:43030733-43031072 | Gliobla | brain: | n/a | n/a |
36 | POLR2A | chr12:43023607-43023620 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr12:43030692-43031067 | MCF-7 | breast: | n/a | n/a |
38 | POLR2A | chr12:43030781-43030981 | A549 | lung: | n/a | n/a |
39 | POLR2A | chr12:43030888-43031010 | HepG2 | liver: | n/a | n/a |
40 | POLR2A | chr12:43030840-43030993 | GM12878 | blood: | n/a | n/a |
41 | POLR2A | chr12:43030741-43030987 | MCF-7 | breast: | n/a | n/a |
42 | POLR2A | chr12:43030770-43030992 | MCF-7 | breast: | n/a | n/a |
43 | POLR2A | chr12:43030738-43030985 | K562 | blood: | n/a | n/a |
44 | POLR2A | chr12:43030771-43031060 | GM12892 | blood: | n/a | n/a |
45 | POLR2A | chr12:43030878-43030991 | GM12878 | blood: | n/a | n/a |
46 | POLR2A | chr12:43030738-43031028 | Hela-S3 | cervix: | n/a | n/a |
47 | POLR2A | chr12:43030722-43030980 | Hela-S3 | cervix: | n/a | n/a |
48 | POLR2A | chr12:43030869-43031005 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | POLR2A | chr12:43030794-43030962 | HepG2 | liver: | n/a | n/a |
50 | POLR2A | chr12:43030858-43031012 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:43031029-43031079 | Caco-2 | colon: | n/a |
2 | chr12:43030949-43030999 | HRPEpiC | eye: | n/a |
3 | chr12:43031000-43031050 | HNPCEpiC | eye: | n/a |
4 | chr12:43030949-43030999 | U87 | brain: | n/a |
5 | chr12:43031029-43031079 | AG04450 | lung: | fetal |
6 | chr12:43031029-43031079 | NHBE | bronchial: | n/a |
7 | chr12:43031029-43031079 | IMR90 | lung: | fetal |
8 | chr12:43031029-43031079 | AG10803 | skin: | n/a |
9 | chr12:43031029-43031079 | HEK293 | kidney: | embryo |
10 | chr12:43031000-43031050 | AoSMC | blood vessel: | n/a |
11 | chr12:43031029-43031079 | SAEC | small airway: | n/a |
12 | chr12:43031000-43031050 | T-47D | breast: | n/a |
13 | chr12:43031000-43031050 | Hepatocyte | liver: | n/a |
14 | chr12:43031000-43031050 | PANC-1 | pancreas: | n/a |
15 | chr12:43031000-43031050 | H1-hESC | embryonic stem cell: | embryo |
16 | chr12:43030949-43030999 | HAEpiC | amniotic membrane: | n/a |
17 | chr12:43031000-43031050 | BJ | skin: | n/a |
18 | chr12:43031000-43031050 | AG09319 | gingival: | n/a |
19 | chr12:43031000-43031050 | U87 | brain: | n/a |
20 | chr12:43030949-43030999 | MCF-7 | breast: | n/a |
21 | chr12:43030949-43030999 | LNCaP | prostate: | n/a |
22 | chr12:43031000-43031050 | HCF | heart: | n/a |
23 | chr12:43031029-43031079 | NHDF-neo | bronchial: | n/a |
24 | chr12:43031029-43031079 | HNPCEpiC | eye: | n/a |
25 | chr12:43031029-43031079 | H1-hESC | embryonic stem cell: | embryo |
26 | chr12:43031029-43031079 | U87 | brain: | n/a |
27 | chr12:43030949-43030999 | CMK | blood: | n/a |
28 | chr12:43031029-43031079 | HEEpiC | esophagus: | n/a |
29 | chr12:43031029-43031079 | HAEpiC | amniotic membrane: | n/a |
30 | chr12:43031000-43031050 | HCM | heart: | n/a |
31 | chr12:43031029-43031079 | SKMC | muscle: | n/a |
32 | chr12:43031000-43031050 | BE2_C | brain: | n/a |
33 | chr12:43031000-43031050 | SKMC | muscle: | n/a |
34 | chr12:43030949-43030999 | H1-hESC | embryonic stem cell: | embryo |
35 | chr12:43030949-43030999 | HUVEC | blood vessel: | n/a |
36 | chr12:43031029-43031079 | HIPEpiC | eye: | n/a |
37 | chr12:43031029-43031079 | Jurkat | blood: | n/a |
38 | chr12:43031000-43031050 | IMR90 | lung: | fetal |
39 | chr12:43031029-43031079 | T-47D | breast: | n/a |
40 | chr12:43031029-43031079 | SK-N-SH_RA | brain: | n/a |
41 | chr12:43031029-43031079 | HRE | kidney: | n/a |
42 | chr12:43031000-43031050 | GM06990 | blood: | n/a |
43 | chr12:43030949-43030999 | HRE | kidney: | n/a |
44 | chr12:43030949-43030999 | MCF10A-Er-Src | breast: | n/a |
45 | chr12:43030949-43030999 | HPAEpiC | pulmonary alveolar: | n/a |
46 | chr12:43030949-43030999 | GM12892 | blood: | n/a |
47 | chr12:43031000-43031050 | HRCEpiC | kidney: | n/a |
48 | chr12:43030949-43030999 | NHBE | bronchial: | n/a |
49 | chr12:43031029-43031079 | LNCaP | prostate: | n/a |
50 | chr12:43031000-43031050 | HPAEpiC | pulmonary alveolar: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:43020347..43023127-chr12:43029388..43031746,2 | K562 | blood: | |
2 | chr12:42976937..42979133-chr12:43031505..43034362,2 | K562 | blood: | |
3 | chr12:43020347..43023127-chr12:43029388..43031746,2 | K562 | blood: | |
4 | chr12:43018191..43020196-chr12:43021950..43023568,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PRICKLE1-1 | chr12:43023263-43023488 | ENSG00000257510 |
2 | lnc-PRICKLE1-3 | chr12:43030617-43030913 | NONHSAT027786 |
3 | lnc-PRICKLE1-1 | chr12:43028083-43028203 | ENSG00000257510 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000257687 | TF binding region |
ENSG00000257405 | TF binding region |
ENSG00000257687 | CpG island |
ENSG00000257405 | CpG island |
ENSG00000257687 | chromatin interactions |
ENSG00000257405 | chromatin interactions |
EGLN3 | miRNA target sites |
POGZ | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7313926 | chr12:43020633-43020634 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs139018072 | chr12:43020666-43020667 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs538026362 | chr12:43020670-43020671 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs79127723 | chr12:43020705-43020706 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs113689305 | chr12:43020709-43020710 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs536122370 | chr12:43020732-43020733 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs143136972 | chr12:43020789-43020790 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs17091505 | chr12:43020797-43020798 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs202197719 | chr12:43020805-43020806 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs147475403 | chr12:43020812-43020813 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs12322671 | chr12:43020819-43020820 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs373992491 | chr12:43020825-43020826 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs7302424 | chr12:43020849-43020850 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs189167570 | chr12:43020856-43020857 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs192872508 | chr12:43020857-43020858 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs7131974 | chr12:43020864-43020865 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs118070832 | chr12:43020879-43020880 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs80034683 | chr12:43020889-43020890 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs527632703 | chr12:43020915-43020916 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs560956630 | chr12:43020924-43020925 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs570576381 | chr12:43020934-43020935 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs531815984 | chr12:43020958-43020959 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs185451647 | chr12:43020993-43020994 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs375361202 | chr12:43021009-43021010 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs189560927 | chr12:43021014-43021015 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs535707028 | chr12:43021072-43021073 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs4768430 | chr12:43021075-43021076 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs566401344 | chr12:43021089-43021090 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs539407658 | chr12:43021093-43021094 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs4768431 | chr12:43021117-43021118 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs17568121 | chr12:43021158-43021159 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs543502204 | chr12:43021226-43021227 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs373818815 | chr12:43021228-43021229 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs149604764 | chr12:43021244-43021245 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs370156328 | chr12:43021301-43021302 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs374074788 | chr12:43021306-43021307 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs78744125 | chr12:43021324-43021325 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs144393593 | chr12:43021349-43021350 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs559193424 | chr12:43021415-43021416 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs533073524 | chr12:43021422-43021423 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs199652951 | chr12:43021431-43021432 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs181106160 | chr12:43021458-43021459 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs7306530 | chr12:43021465-43021466 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs148810400 | chr12:43021466-43021467 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs550237946 | chr12:43021549-43021550 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs7306683 | chr12:43021575-43021576 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs529440683 | chr12:43021577-43021578 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs531702537 | chr12:43021587-43021588 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs7303511 | chr12:43021604-43021605 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs376785206 | chr12:43021627-43021628 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:43017000-43020800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr12:43020800-43021000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr12:43020800-43021200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr12:43021000-43021800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr12:43021400-43022000 | Enhancers | Fetal Stomach | stomach |
6 | chr12:43024400-43026200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
7 | chr12:43024800-43026000 | Enhancers | Primary monocytes fromperipheralblood | blood |
8 | chr12:43025000-43026000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr12:43025200-43025600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr12:43025200-43026000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr12:43025200-43026600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr12:43025600-43026000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr12:43025600-43029400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr12:43025800-43026200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr12:43026000-43029400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr12:43029400-43030000 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr12:43029400-43030600 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr12:43030000-43030400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr12:43030200-43030400 | Enhancers | Aorta | Aorta |
20 | chr12:43030400-43030600 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
21 | chr12:43030600-43035000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
22 | chr12:43031600-43032800 | Enhancers | HUVEC | blood vessel |